Perspectives of Clinicians in the United States and Europe on Monitoring Levels of Biologic Agents in Patients Receiving Biologic Therapies for Inflammatory Bowel Diseases.

Perspectives of Clinicians in the United States and Europe on Monitoring Levels of Biologic Agents in Patients Receiving Biologic Therapies for Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2019 08; 17(9):1718-1723.

View in: PubMed

subject areas

Biological Factors
Biological Therapy
Drug Monitoring
Europe
Humans
Inflammatory Bowel Diseases
United States

authors with profiles

Stephen B. Hanauer